Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS

類似資料

• Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study
  著者:: Cohen, Jeffrey A, 等
  出版事項: (2016)
• Fingolimod in the treatment of relapsing–remitting multiple sclerosis: long-term experience and an update on the clinical evidence
  著者:: Khatri, Bhupendra O.
  出版事項: (2016)
• Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study
  著者:: Freedman, Mark S., 等
  出版事項: (2014)
• Fingolimod
  著者:: Hyland, Megan H., 等
  出版事項: (2011)
• Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
  著者:: Karlsson, Goeril, 等
  出版事項: (2014)